Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Gastrointestinal 4Tumor-Agnostic 3Myeloid 3Dermatologic 3Thoracic 2Head & Neck 2Other neoplasm 1Other hematologic neoplasm 1NET 1Lymphoid 1Gynecologic 1Genitourinary 1Endocrine 1Classical hematology 1CNS 1

Conditions

Lung Neoplasms 1Locally Advanced Head and Neck Carcinoma 1Head and Neck Neoplasms 1

Interventions

Cisplatin 30pembrolizumab 24Magnetic Resonance Spectroscopy 24Specimen Handling 20Cetuximab 18Nivolumab 15Carboplatin 14Platinum 121,2-diaminocyclohexaneplatinum II citrate 12Radiotherapy, Intensity-Modulated 11Radiotherapy 10Radiation 9Paclitaxel 9Docetaxel 8Biopsy 8Immunoglobulin G 7Disulfides 7Surveys and Questionnaires 6Ipilimumab 6atezolizumab 5Fluorouracil 5toripalimab 4dostarlimab 4cemiplimab 4cabozantinib 4Taxes 4Gemcitabine 4CTLA-4 Antigen 4Bevacizumab 4(225)Ac-DOTA-c(RGDyK) 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Blood Specimen Collection × Head & Neck × 30 days × Clear all
NCT02597738 2026-05-29

A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine

University of Arkansas

Phase NA Active not recruiting
330 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT05710679 2026-05-26

NeckTAR

Centre Jean Perrin

Phase NA Recruiting
63 enrolled
Head & Neck

Locally Advanced Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡